{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:23:33Z","timestamp":1790839413654,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/bf02893852","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T23:02:56Z","timestamp":1231542176000},"page":"205-210","source":"Crossref","is-referenced-by-count":35,"title":["Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia"],"prefix":"10.1007","volume":"11","author":[{"given":"G\u00e1bor","family":"M\u00e9hes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02893852_CR1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00277-004-0869-4","volume":"83","author":"U Bacher","year":"2004","unstructured":"Bacher U, Kern W, Schock C, et al: Discrimination of chronic iymphocytic leukemia (CLL) and CLL\/PL by cytoinorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH). Ann Hematol 83: 349\u2013355, 2004.","journal-title":"Ann Hematol"},{"key":"BF02893852_CR2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0002-9440(10)64256-3","volume":"161","author":"S Bea","year":"2002","unstructured":"Bea S, Lopez-Guillermo A, Ribas M, et al: Genetic imbalances in chronic Iymphocytic leukemia and transformed large-cell lymphoma (Richters syndrome). Am J Pathol 161: 957\u2013968, 2002.","journal-title":"Am J Pathol"},{"key":"BF02893852_CR3","doi-asserted-by":"crossref","unstructured":"Byrd JC, Stilgenbauer S, Flinn IW: Chronic Iymphocytic leukemia. Hematology 163\u2013183, 2004.","DOI":"10.1182\/asheducation-2004.1.163"},{"key":"BF02893852_CR4","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.1073\/pnas.0404432101","volume":"101","author":"GA Calin","year":"2004","unstructured":"Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling reveals distinct signatures in B cell chronic Iymphocytic leukemias. Proc Natl Acad Sci USA 101: 11755\u201311760, 2004.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02893852_CR5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.leu.2403537","volume":"18","author":"D Capello","year":"2004","unstructured":"Capello D, Guarini A, Berra E, et al: Evidence of biased immunoglobulin variable gene usage in highly-stable B-cell chronic leukemia. Leukemia 18: 1941\u20131947, 2004.","journal-title":"Leukemia"},{"key":"BF02893852_CR6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.leu.2403242","volume":"18","author":"A Cuneo","year":"2004","unstructured":"Cuneo A, Rigolin GM, Bigoni R, et al: Chronic Iymphocytic leukemia with 6q-shows distinct hematological features and intermediate prognosis. Leukemia 18: 476\u2013483, 2004.","journal-title":"Leukemia"},{"key":"BF02893852_CR7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ejhg.5201220","volume":"12","author":"D Jong De","year":"2004","unstructured":"De Jong D, van\u2019t Veer LJ: Tools for molecular risk-stratification for clinical purposes: CLL as a prototype. Eur J Hum Genet 12: 423, 2004.","journal-title":"Eur J Hum Genet"},{"key":"BF02893852_CR8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bbrc.2003.10.054","volume":"311","author":"MT Fuente De la","year":"2003","unstructured":"De la Fuente MT, Casanova B, Cantero E, et al: Involvement of p53 in alpha4betal integrin-mediated resistance of B-CLL cells to fludarabine. Biochem Biophys Res Commun 311: 708\u2013712, 2003.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02893852_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2141.2003.04265.x","volume":"121","author":"GW Dewald","year":"2003","unstructured":"Dewald GW, Brockman SR, Paternoster SF, et al: Chromosome anomalies detected by fluorescence in situ hybridisation: correlation with significant biological features in B-cell chronic lymphocytic leukemia. Br J Haematol 121: 287\u2013295, 2003.","journal-title":"Br J Haematol"},{"key":"BF02893852_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s001090050350","volume":"77","author":"H D\u00f6hner","year":"1999","unstructured":"D\u00f6hner H, Stilgenbauer S, D\u00f6hner K, et al: Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 77: 266\u2013281, 1999.","journal-title":"J Mol Med"},{"key":"BF02893852_CR11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cancergencyto.2004.08.012","volume":"158","author":"AB Glassman","year":"2005","unstructured":"Glassman AB, Hayes KJ: The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet 158: 88\u201391, 2005.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF02893852_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-5793(03)01371-1","volume":"556","author":"M Hammarsund","year":"2004","unstructured":"Hammarsund M, Corcoran MM, Wilson W, et al: Characterization of a novel B-CLL candidate gene \u2014 DLEU \u2014 in the 13q14 tumor suppressor locus. FEBS Lett 556: 75\u201380, 2004.","journal-title":"FEBS Lett"},{"key":"BF02893852_CR13","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1200\/JCO.2004.12.133","volume":"22","author":"C Haslinger","year":"2004","unstructured":"Haslinger C, Schweifer N, Stilgenbauer S, et al: Microarray gene expression profiling of B-cell chronic iymphoid leukemia subgroups defined by genomic aberrations and VH mutation status. J Clin Oncol 22: 3937\u20133949, 2004.","journal-title":"J Clin Oncol"},{"key":"BF02893852_CR14","first-page":"2140","volume":"9","author":"JM Hernandez","year":"1995","unstructured":"Hernandez JM, Mecucci C, Criel A, et al: Cytogenetic analysis of B-cell chronic lymphocytic leukemias classified according to morphologic and immunophenotypic criteria. Leukemia 9: 2140\u20132146, 1995.","journal-title":"Leukemia"},{"key":"BF02893852_CR15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/gcc.10227","volume":"37","author":"R Karhu","year":"2003","unstructured":"Karhu R, Tobin G, Thunberg U, et al: More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukemia. Genes Chromosomes Cancer 37: 417\u2013420, 2003.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF02893852_CR16","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","volume":"100","author":"A Kr\u00f6ber","year":"2002","unstructured":"Kr\u00f6ber A, Seller T, Benner A, Bullinger L, et al: VH mutation status, CD38 expression level, genomic aberrations and survival in chronic lymphocytic leukemia. Blood 100: 1410\u20131416, 2002.","journal-title":"Blood"},{"key":"BF02893852_CR17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10428199909050950","volume":"34","author":"A Matolcsy","year":"1999","unstructured":"Matolcsy A: High-grade transformation of low-grade non-Hodgkiu\u2019s lymphomas: mechanisms of tumor progression. Leuk Lymphoma 34: 251\u2013259, 1999.","journal-title":"Leuk Lymphoma"},{"key":"BF02893852_CR18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10245330400020470","volume":"10","author":"Z Matrai","year":"2005","unstructured":"Matrai Z: CD38 as a prognostic marker in CLL. Hematology 10: 39\u201346, 2005.","journal-title":"Hematology"},{"key":"BF02893852_CR19","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1080\/10428190410001710812","volume":"45","author":"C Matthews","year":"2004","unstructured":"Matthews C, Catherwood M, Morris TC, Alexander HD: Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols. Leuk Lymphoma 45: 1899\u20131904, 2004.","journal-title":"Leuk Lymphoma"},{"key":"BF02893852_CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20040544","volume":"200","author":"BT Messmer","year":"2004","unstructured":"Messmer BT, Albesiano E, Efremov DG, et al: Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 200: 519\u2013525, 2004.","journal-title":"J Exp Med"},{"key":"BF02893852_CR21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(03)15260-9","volume":"363","author":"JA. Orchard","year":"2004","unstructured":"Orchard JA., Ibbotson RE, Davis Z, et al: ZAP-70 expression and prognosis in chronic lymphocytic leukemia. Lancet 363: 105\u2013111, 2004.","journal-title":"Lancet"},{"key":"BF02893852_CR22","first-page":"769","volume":"88","author":"L Ottaggio","year":"2003","unstructured":"Ottaggio L, Viaggi S, Zunino A, et al: Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression. Haematologica 88: 769\u2013777, 2003.","journal-title":"Haematologica"},{"key":"BF02893852_CR23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V82.2.571.571","volume":"82","author":"TH Que","year":"1993","unstructured":"Que TH, Marco JG, Ellis J, et al: Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype and morphology. Blood 82: 571\u2013575, 1993.","journal-title":"Blood"},{"key":"BF02893852_CR24","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1639","volume":"194","author":"A Rosenwald","year":"2001","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G, et al: Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194: 1625\u20131638, 2001.","journal-title":"J Exp Med"},{"key":"BF02893852_CR25","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2003-09-3236","volume":"104","author":"A Rosenwald","year":"2004","unstructured":"Rosenwald A, Chuang EY, Davis RE, et al: Fludarabine treatment of patients with chronic lymphocytic leukemia induces p53 dependent gene expression response. Blood 104: 1428\u20131434, 2004.","journal-title":"Blood"},{"key":"BF02893852_CR26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1073\/pnas.0304717101","volume":"101","author":"C Schwaenen","year":"2004","unstructured":"Schwaenen C, Nessling M, Wessendorf S, et al: Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 101: 1039\u20131044, 2004.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02893852_CR27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1080\/1042819021000002884","volume":"42","author":"T Stankovic","year":"2002","unstructured":"Stankovic T, Stewart GS, Byrd P, et al: ATM mutations in sporadic iymphoid tumors. Leuk Lymphoma 42: 1563\u20131571, 2002.","journal-title":"Leuk Lymphoma"},{"key":"BF02893852_CR28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2003-04-1161","volume":"103","author":"T Stankavic","year":"2004","unstructured":"Stankavic T, Hubank M, Cronin D, et al: Microarray analysis reveals that TP-53 and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses. Blood 103: 291\u2013300, 2004.","journal-title":"Blood"},{"key":"BF02893852_CR29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.leu.2403249","volume":"18","author":"B Timor","year":"2004","unstructured":"Timor B, F\u00fcl\u00f6p Z, Csernus B, et al: Relationship between the mutational status of VH genes and the pathogenesis of diffuse large B-cell lymphoma in Richter\u2019s syndrome. Leukemia 18: 326\u201330, 2004.","journal-title":"Leukemia"},{"key":"BF02893852_CR30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cncr.20773","volume":"103","author":"AM Tsimberiodu","year":"2004","unstructured":"Tsimberiodu AM, Keating MJ: Richter syndrome. Biology, incidence and therapeutic strategies. Cancer 103: 216\u2013228, 2004.","journal-title":"Cancer"},{"key":"BF02893852_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.thj.6200325","volume":"5","author":"PD Thornton","year":"2004","unstructured":"Thornton PD, Gruszka-Westwood AM., Hatnoudi RA, et al: Characterization of TP53 abnormalities in chronic lymphocytic leukemia. Hematol J 5: 47\u201354, 2004.","journal-title":"Hematol J"},{"key":"BF02893852_CR32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2141.2005.05405.x","volume":"129","author":"M Valganon","year":"2005","unstructured":"Valganon M, Giraldo P, Agirre X, et al: P53 aberrations do not predict individual response to fiudarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III\/IV. Br J Haematol 129: 53\u20139, 2005.","journal-title":"Br J Haematol"},{"key":"BF02893852_CR33","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","volume":"101","author":"A Wiestner","year":"2003","unstructured":"Wiestner A, Rosenwald A, Barry TS, et al: ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunogiobulin genes, inferior clinical outcome and distinct gene expression profile. Blood 101: 4944\u20134951, 2003.","journal-title":"Blood"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02893852.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02893852\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02893852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T14:38:41Z","timestamp":1589467121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02893852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["BF02893852"],"URL":"https:\/\/doi.org\/10.1007\/bf02893852","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}